Avantor Sees Unusually Large Options Volume (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTR - Get Free Report) was the recipient of unusually large options trading on Thursday. Stock investors purchased 29,996 put options on the company. This is an increase of 463% compared to the typical volume of 5,332 put options.

Wall Street Analyst Weigh In

Several brokerages have commented on AVTR. Barclays cut their price objective on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research report on Friday, October 25th. Royal Bank of Canada restated an "outperform" rating and issued a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. UBS Group reaffirmed a "neutral" rating and issued a $25.00 price target (down previously from $29.00) on shares of Avantor in a research note on Friday. Robert W. Baird lowered their price objective on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research report on Monday, October 28th. Finally, Wells Fargo & Company reduced their target price on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company's stock. According to MarketBeat.com, Avantor currently has an average rating of "Moderate Buy" and a consensus price target of $27.38.

Avantor Stock Down 1.9 %

Avantor stock traded down $0.43 during mid-day trading on Friday, reaching $22.14. 6,042,606 shares of the company were exchanged, compared to its average volume of 4,492,800. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The firm has a market cap of $15.07 billion, a P/E ratio of 48.13, a PEG ratio of 3.42 and a beta of 1.28. The business has a fifty day moving average of $21.46 and a 200 day moving average of $23.34. Avantor has a 12-month low of $19.59 and a 12-month high of $28.00.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the stock. MassMutual Private Wealth & Trust FSB grew its stake in Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock valued at $26,000 after purchasing an additional 625 shares during the last quarter. UMB Bank n.a. bought a new stake in shares of Avantor in the 3rd quarter valued at about $49,000. Nisa Investment Advisors LLC boosted its holdings in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock valued at $53,000 after buying an additional 835 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock worth $70,000 after buying an additional 1,285 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its stake in shares of Avantor by 278.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company's stock worth $130,000 after acquiring an additional 3,700 shares in the last quarter. 95.08% of the stock is owned by institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.